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Lack of health insurance is a barrier to medical care, which may
increase the risk of diabetes complications and costs. The object-
ive of this study was to assess the potential of the Affordable Care
Act (ACA) of 2010 to improve diabetes care through increased
health care access by comparing health care and health outcomes
of insured and uninsured people with diabetes.
Methods
We examined demographics, access to care, health care use, and
health care expenditures of adults aged 19 to 64 years with dia-
betes by using the 2011 and 2012 Medical Expenditure Panel Sur-
vey. Bivariate descriptive statistics comparing insured and unin-
sured persons were evaluated separately by income above and be-
low 138% of the federal poverty level (FPL), (a threshold for ex-
panded Medicaid eligibility in select states under the ACA) using
the t test and proportion and median tests.
Results
Uninsured  adults  reported  poorer  access  to  care  than  insured
adults,  such as having a usual source of health care (69.0% vs
89.5% [≤138% FPL], 77.1% vs 94.6% [>138% FPL], both P <
.001) and having lower rates of 6 key diabetes preventive care ser-
vices (P ≤ .05). Insured adults with diabetes had significantly high-
er  health  care  expenditures  than uninsured adults  ($13,706 vs
$4,367, $10,838 vs $4,419, respectively, both P < .001).
Conclusion
Uninsured adults with diabetes had less access to health care and
lower levels of preventive care, health care use, and expenditures
than insured adults. To the extent that the ACA increases access
and coverage, uninsured people with diabetes are likely to signific-
antly increase their health care use, which may lead to reduced in-
cidence of diabetes complications and improved health.
Introduction
In 2012, more than 29 million Americans were living with dia-
gnosed diabetes (1). The serious health challenges facing people
with diabetes include heart disease, stroke, hypertension, kidney
disease, neuropathy, and blindness (2). Researchers estimate that
the economic burden to society of diagnosed diabetes reached
$245 billion in 2012 (3). Although private and public health insur-
ance programs provide important access to health care for some
people with diabetes, millions of working-age adults with dia-
betes lack health insurance (4). This suggests that a high propor-
tion of the population with diabetes faces significant challenges in
access  to  health  care,  which may lead to  suboptimal  care,  in-
creased rates of long-term complications, and greater health care
expenditures.
The Affordable Care Act (ACA) of 2010 is designed to provide
access to coverage for previously uninsured Americans. Adults
with incomes below 138% of the federal poverty level (FPL) will
gain access to Medicaid coverage in states that expand coverage
(5) (28 states including the District of Columbia as of January 24,
2015). People with incomes above the poverty level in all states
can obtain access to private insurance plans in health insurance
“marketplaces.” In addition, premiums in these marketplaces are
subsidized for people with household incomes between 100% and
399% of the FPL (6). An estimated 60% of the uninsured will ob-
tain health insurance through one or the other of these 2 methods
by 2019 (7). As of September 2014, ACA had reduced the num-
ber of uninsured by more than 9 million (8), although a separate
breakdown for people with diabetes was not available.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health
and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
www.cdc.gov/pcd/issues/2015/14_0431.htm • Centers for Disease Control and Prevention      1
Previous published work has shown that the uninsured face signi-
ficant barriers to obtaining health care and face higher out-of-
pocket health care costs than the insured (9). In addition, the unin-
sured can experience health problems as a result of the lack of ac-
cess to medical care. Although much research has focused on the
general uninsured population, few studies have focused on the
population with diabetes. A study similar to ours focused on Medi-
caid and diabetes, although the authors used older data and did not
include people with higher incomes (10), who are also affected by
ACA. In addition, because health care reform, one of the most im-
portant social policy changes in the United States in decades, is
now nearly fully implemented, no studies have taken a snapshot of
the uninsured US population with diabetes and considered how
their medical care may be changing under full implementation of
ACA in 2014 and beyond.
The objective of this study was to gauge the potential impact of
ACA on improving diabetes care through improved health care ac-
cess by comparing health care and health outcomes of a large na-
tional sample of insured and uninsured adults with diabetes. Our
results provide a straightforward comparison of the gap between
the insured and uninsured before health care reform and insights
about how indicators for these 2 groups may converge in coming
years.
Methods
To obtain the latest pre-ACA snapshot of the US population with
diabetes, we pooled data from the 2 most recent years of the Med-
ical Expenditure Panel Survey (MEPS), the 2011 and 2012 house-
hold component full-year consolidated data files (11,12). (This
period is “pre-ACA” because major provisions were not effective
until 2014, although limited features such as expanded coverage
for young adults began in 2010.) MEPS is an ongoing set of sur-
veys sponsored by the Agency for Healthcare Research and Qual-
ity (AHRQ) that collects nationally representative data on health
services and expenditures of the noninstitutionalized civilian pop-
ulation. MEPS is constructed from a subsample of households par-
ticipating in the National Health Interview Survey and uses a strat-
ified random sample design and computer-assisted in-person inter-
views  (13).  MEPS  is  well  suited  for  this  analysis  because  it
provides detailed information on health care use and expenditures
and also includes survey responses, capturing data on items such
as  health  care  access.  Other  national  surveys  and  claims  data
provide one or the other type of data but rarely both.
MEPS respondents are interviewed 3 times during a calendar year
and asked several questions about health care use, insurance, ex-
penditures, access to care, preventive care services, and chronic
diseases. People with diabetes are asked about health outcomes
and health care specific to diabetes. For many measures on the
full-year consolidated file, MEPS combines data from each re-
spondent’s multiple interviews to create 1 calendar year variable.
We restricted the study sample to adults aged 19 to 64 years who
reported that they had been diagnosed with diabetes (most people
over age 65 with diabetes are unaffected by ACA coverage provi-
sions, because they are eligible for Medicare.) We stratified ana-
lysis by household income at less than 138% of the FPL (here-
after, low income) and greater than 138% of the FPL (hereafter,
high income), because these are the eligibility limits for Medicaid
in states choosing to expand coverage.
We used edited variables when possible, which are cleaned for
consistency  by  AHRQ  across  the  multiple  survey  rounds  in
MEPS. These variables included age, sex, race/ethnicity, educa-
tion, census region, and health insurance status. We collapsed the
level of detail on variables such as employment, because these
measures serve only as controls intended to identify systematic
differences between the sample groups and are not primary as-
pects of diabetes care or outcomes. All outcomes, which are meas-
ured over a period of time (employment, insurance, access to care,
diabetes care, health care use, and health care expenditures), were
limited to the current year, 2011 or 2012, for the corresponding
MEPS sample. For ease of exposition, we created the following
mutually exclusive groups for the previous 12 months out of the
monthly MEPS insurance indicators in the following order: dual
eligible (Medicaid and Medicare), Medicaid, Medicare, private in-
surance, TRICARE and Civilian Health and Medical Program of
the Department of Veterans Affairs (CHAMPVA), and other pub-
lic  insurance.  People  with  more  than  1  insurance  type  were
grouped into the first applicable type in the insurance indicator
list.
Diabetes-specific measures were from the MEPS Diabetes Care
Survey (DCS), a paper-and-pencil survey module administered to
those reporting that they had ever been diagnosed with diabetes.
The DCS includes self-report of the year of diagnosis, of ever hav-
ing had diabetes complications of the eye or kidney, and of receiv-
ing 6 preventive care measures in the past year (hemoglobin A1c
blood test, feet checked for sores or irritations, dilated eye examin-
ation, blood cholesterol check, influenza vaccination, and blood
pressure checks). We calculated the years since diabetes was first
diagnosed as the difference between the respondent’s age at inter-
view and the age at diagnosis. We used the DCS-specific survey
weight when reporting DCS measures.
For physical health and comorbidities, we analyzed self-reported
body mass index (BMI) (kg in weight/m2 in height) and the pre-
valence of all adult priority conditions, as defined by AHRQ (14).
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In addition to diabetes, the conditions are hypertension, heart dis-
ease (coronary heart disease, angina, myocardial infarction, other
unspecified heart disease), stroke, emphysema, chronic bronchitis,
high cholesterol, cancer, joint pain, arthritis, and asthma. Several
of these are either linked to diabetes as complications associated
with diabetes management and duration; others are risk factors
that present additional challenges to proper diabetes care.
We included 3 broad measures of access, measured as binary in-
dicators. All respondents were asked if they had a usual source of
medical care in the past year. Respondents were also asked if they
were ever unable to access necessary medical care in the past year
and if they were unable to get necessary prescription medications.
For health care use in the past year,  we studied the number of
physician or clinic office visits and total number of prescriptions.
We included binary indicators for any emergency department visit
and any inpatient hospital nights, because these services are used
infrequently and their statistical distribution is skewed. We ex-
amined total health care expenditures, out-of-pocket health care
expenditures, and prescription drug expenditures, which included
diabetes supplies.
Survey-specific  procedures  in  Stata  13.1  (StataCorp LP)  with
weighted analyses and analytic subpopulations were used. To pool
the 2011–12 data, we halved the survey weights so that the results
equally represented people with diabetes for 2011 and 2012. Dif-
ferences between insured and uninsured people were examined
separately  by  income  group  using  means,  proportions,  and
crosstabs. Tests of significance were computed using survey-spe-
cific t tests, proportions, and χ2 tests. We also computed medians
of health care expenditure and use data and tested differences by
using the nonparametric k-sample test on equality of medians.
Results
We estimated from MEPS that from 2011 through 2012, more
than 13 million adults in the United States aged 19 to 64 years
were living with diagnosed diabetes, and nearly 2 million of them
lacked health insurance (Table 1).  The prevalence of  diabetes
ranged  from 4.8%  among the  uninsured  with  incomes  above
138% of the FPL to 10.5% among the insured with incomes at or
below 138% of the FPL (Table 1); in both income groups, insured
persons were more likely to have diabetes than uninsured persons
(P < .001).
Differences by insurance status suggest some patterns that may be
related to both the likelihood of having insurance and the preval-
ence of diabetes. In both income groups, uninsured persons were
more likely to be nonwhite (P = .007, low income; P < .001, high
income). Among the low-income groups, uninsured people with
diabetes  (42.7%) were more likely than the insured to be em-
ployed (26.5%) (P < .001). Significant regional differences by in-
surance status were also apparent among the low-income groups
(P = .002); more than 55% of low-income uninsured adults and
only 39% of insured adults resided in states in the southern census
region.
High-income, insured adults with diabetes had a higher average
BMI than uninsured adults (33.5 vs 31.5, P = .002); this was also
the case with overweight adults  (P = .02) and those with high
levels of morbid obesity (class II/III, P = .01). Low-income in-
sured adults had significantly higher rates of 7 chronic conditions
(heart disease, stroke, emphysema, bronchitis, joint pain, arthritis,
asthma) than those without insurance (all P < .01 or smaller), and
high-income people had higher rates of 2 conditions (high choles-
terol and arthritis) (both P < .05).
Significant differences in health care access were seen in both in-
come groups, both in having a usual source of care (P < .001) and
being unable to access necessary health care (P < .001). Low-in-
come people were also much more likely to report that they were
unable to get necessary prescription medications (P = .002). Signi-
ficant differences by insurance status for all 6 recommended dia-
betes preventive care services (ie, Hemoglobin A1c [HbA1c] test,
foot examination, eye examination, blood cholesterol check, influ-
enza vaccine, and blood pressure check) were found across in-
come groups (P ≤ .05).
In both income groups, insured adults with diabetes were much
more likely to have used medical services in the past year than
those without health insurance (Table 2). For instance, in the low-
income group, the mean number of annual office visits among the
insured was nearly triple the mean number among the uninsured
(P < .001) and nearly double that among the high-income group (P
< .001). The mean number and the median number of prescrip-
tions were also substantially higher among the insured in both in-
come groups (P < .001). The likelihood of using emergency de-
partment services (P = .001) or having inpatient hospital nights (P
< .001) in the past year was significantly greater (P < .001) among
the low-income group than the high-income group.
Differences in health care use and differences in expenditures
between the insured and uninsured in both income groups were
large. Mean total expenditures were much greater among the in-
sured, which probably reflects greater access to health care: nearly
$6,400 higher for those with incomes above 138% of the FPL (P <
.001) and more than $9,300 higher for those with incomes at or
below138% FPL (P < .001).  Median differences were slightly
smaller but still significant for both groups (P < .001). Out-of-
pocket expenditures were higher among the uninsured only in the
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low-income group. Prescription drug expenditures were a signific-
ant driver of total expenses and were much greater among the in-
sured than uninsured for both income groups (P < .001).
Discussion
Our findings showed that from 2011 through 2012, shortly after
passage of ACA, nearly 2 million working-age adults with dia-
betes lacked health insurance. We also showed that access to care
was a significant barrier among this population and that proper
diabetes care lagged among the insured on all indicators. Thus, the
potential of ACA to improve health and health care for people
with diabetes appears to be large. If the health care patterns of the
uninsured in 2011–12 move toward those of the insured, our res-
ults suggest that expanded insurance coverage will likely increase
health care costs in the short-term for people with diabetes. Al-
though long-term effects were beyond the scope of our research, it
is possible that these may be more favorable for health outcomes
and expenditures. For example, a recent study found that weight
loss among people with diabetes reduced health expenditures over
10 years (15), and other health care interventions have also been
shown to reduce the burden of diabetes (16). Counterbalancing
these findings are the findings from the Oregon Health Insurance
Experiment (17), in which newly acquired Medicaid did not signi-
ficantly reduce average HbA1c during the first 2 years of cover-
age. Our findings are consistent with that study in that we found
higher rates of diagnosed diabetes and greater use of prescription
medications among the insured than the uninsured samples.
Our findings showed that uninsured adults with diabetes undergo
different patterns of care than those with health insurance. For in-
stance, in our study the uninsured were much less likely to obtain
prescriptions, make office visits to physicians, and to have a usual
source of  care.  Rates  of  current  multiple  disorders,  several  of
which are associated with diabetes, were greater among the in-
sured than the uninsured in both income groups; differences were
significant for 6 conditions among the low-income sample and for
2 conditions among the high-income sample. Possible explana-
tions include self-selection, in which those who have a greater
need for care seek insurance voluntarily, or improved access, in
which the insured are diagnosed for these conditions at higher
rates (4).  The percentage of respondents reporting fair or poor
health was nearly 10 points higher among the high-income unin-
sured group (P = .02), possibly supporting an access theory, al-
though no significant differences were seen among the low-in-
come group.
The observed disconnect between patterns of care provided and
need for care suggests that as uninsured adults with diabetes ob-
tain new health insurance under full implementation of ACA in
2014 and beyond, we should expect their use of medical care to in-
crease significantly — more office visits, prescriptions, and use of
inpatient care. Our results distinguish between people with in-
comes  below 138% of  the  FPL who  will  become eligible  for
Medicaid (in states expanding Medicaid) and those people with in-
comes  above  138% of  the  FPL;  results  also  demonstrate  that
health care use should increase for both groups, although the gap
in services is larger among low-income persons, suggesting great-
er potential demand among low-income persons. However, many
other barriers to good diabetes care exist, besides health insurance,
that are not directly targeted by ACA, including education, liter-
acy, language, attitudes, beliefs, and social support (18).
Given the longstanding finding (19) that the uninsured face diffi-
culties obtaining access to a usual source of health care, it is not
surprising that uninsured adults with diabetes in both the high- and
low-income groups we studied were significantly less likely to re-
port having a usual source of care (P < .001). Greater total ex-
penditures among the insured probably reflect access, or the ease
of obtaining necessary medical care.  Early observations in the
Oregon studies indicate similar trends (20). The fact that our find-
ings show that  inpatient and emergency department services were
greater among the insured parallels findings in Oregon (21) and
recent qualitative evidence (22). Furthermore, among those with
Medicaid,  access  to  primary care  providers  may be limited in
some areas, given low provider reimbursement rates.
Our results should be interpreted with caution. First, our study
compares descriptive results. A more detailed comparison could
use multivariate analysis to control for associations between vari-
ables presented here. The descriptive findings here serve as a start-
ing point and guide for future research.
Second, our results are based on cross-sectional data, so we can-
not assign causation to the differences in health status, outcomes,
and health care use, access, or expenditures between uninsured
and insured people. People with health insurance are likely to be
different from those without health insurance in some important
ways, both observable and unobservable. Multivariate models can
control for the observables, although some of the differences we
found probably reflect both observable and unobservable factors.
Our goal with this analysis was not to estimate causal inference.
Rather, we sought to address the research gap in the literature on
differences  between  the  uninsured  and  insured  population  of
people with diabetes, above and below the average Medicaid eli-
gibility cutoff of 138% FPL, by assessing numerous health out-
comes and health care access and use measures. The fact that our
demographic indicators show a high level of Medicaid use by the
income group at or below 138% FPL and a high level of private
insurance by the over-138% FPL group supports the value of such
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a comparison. That is, the uninsured in each group who become
insured after ACA are likely to receive most of their coverage
through the dominant form of insurance for that income group
(Medicaid for low income, private insurance for high income). Al-
though we expect some changes in patterns of health care and
health care use to result from changes in coverage, measurement
of the actual effects will need to be conducted in future research
studies after additional years of post-ACA implementation data are
available. We also see relatively few differences in demographics
between the insured and uninsured, except for nonwhite race/eth-
nicity and region, which is probably due to the more restrictive
Medicaid income criteria for low-income adults in Southern states.
Third, the study is limited to adults aged 19 to 64 years, so the
findings here cannot be extended to children or the elderly, al-
though they are less directly targeted by ACA. Fourth, the MEPS
measure of the diabetes population reflects currently diagnosed
adults. The population with undiagnosed diabetes is sizable (4),
and some of these people may be newly diagnosed under ACA as
a result  of  improved health  care  access.  On the one hand,  the
highest rate of undiagnosed diabetes is found among the unin-
sured (4), so our findings may be viewed as underestimates of the
potential number of uninsured people with diabetes who could be
assisted by implementation of ACA. We could not identify adults
in the diabetes population who may or will not be eligible for cov-
erage under ACA (noncitizens or persons living in states that will
not expand Medicaid); this nonidentification would overstate the
number of uninsured people with diabetes who could be assisted
by implementation of the ACA.
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Tables
Table 1. Health and Demographic Characteristics of US Adults With Diabetes Aged 19 to 64 Years, Medical Expenditure
Panel Survey 2011 and 2012
Characteristica








(95% CI) P Valuec
Diabetes prevalence 5.6 (4.8–6.6) 10.5
(9.3–11.6)
<.001 4.8 (4.0–5.6) 6.7 (6.1–7.2) <.001
Unweighted sample (n = 1,568) 325 774 — 318 1791 —
Weighted sample (n = 13,084,968) 770,404 2,529,894 — 1,024,650 8,704,030 —
Demographic characteristic



























































































Both Medicaid and Medicare — 17.1 — 2.6 (1.8–3.8)
Abbreviations: BMI, body mass index; CI, confidence interval.
a Values are percentages unless otherwise noted.
b Tests of insurance status are between >138% federal poverty level insured and ≤138% federal poverty level. All other tests are by insurance status
within income groups. All results were weighted to be nationally representative.
c Tests of significance were computed by using survey-specific t tests for continuous variables, proportions tests for binary variables, and χ2 tests for
proportions.
d TRICARE/CHAMPVA is coverage for military families and dependents through the TRICARE system and Civilian Health and Medical Program of the De-
partment of Veterans Affairs (CHAMPVA).
e Obese class II = BMI 35.0–39.9; obese class III = BMI ≥40.
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(continued)
Table 1. Health and Demographic Characteristics of US Adults With Diabetes Aged 19 to 64 Years, Medical Expenditure
Panel Survey 2011 and 2012
Characteristica








(95% CI) P Valuec
(13.2–21.8)







Other public insurance — 1.0 (0.4–2.4) — 0.8 (0.4–1.7)
Diabetes and associated conditions








































































Coronary heart disease, angina, acute














Emphysema 1.2 (0.0–2.6) 6.2 (4.7–7.7) .002 1.8 (0.0–4.1) 1.8 (1.0–2.6) .97
Chronic bronchitis 4.5 (1.5–7.6) 12.4 .004 8.0 5.5 (3.7–7.2) .36
Abbreviations: BMI, body mass index; CI, confidence interval.
a Values are percentages unless otherwise noted.
b Tests of insurance status are between >138% federal poverty level insured and ≤138% federal poverty level. All other tests are by insurance status
within income groups. All results were weighted to be nationally representative.
c Tests of significance were computed by using survey-specific t tests for continuous variables, proportions tests for binary variables, and χ2 tests for
proportions.
d TRICARE/CHAMPVA is coverage for military families and dependents through the TRICARE system and Civilian Health and Medical Program of the De-
partment of Veterans Affairs (CHAMPVA).
e Obese class II = BMI 35.0–39.9; obese class III = BMI ≥40.
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(continued)
Table 1. Health and Demographic Characteristics of US Adults With Diabetes Aged 19 to 64 Years, Medical Expenditure
Panel Survey 2011 and 2012
Characteristica








(95% CI) P Valuec
(8.1–16.7) (2.9–13.1)








































Self-rated general health as fair or poor









Abbreviations: BMI, body mass index; CI, confidence interval.
a Values are percentages unless otherwise noted.
b Tests of insurance status are between >138% federal poverty level insured and ≤138% federal poverty level. All other tests are by insurance status
within income groups. All results were weighted to be nationally representative.
c Tests of significance were computed by using survey-specific t tests for continuous variables, proportions tests for binary variables, and χ2 tests for
proportions.
d TRICARE/CHAMPVA is coverage for military families and dependents through the TRICARE system and Civilian Health and Medical Program of the De-
partment of Veterans Affairs (CHAMPVA).
e Obese class II = BMI 35.0–39.9; obese class III = BMI ≥40.
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Table 2. Health Care Access, Use, and Expenditures of US Adults Aged 19 to 64 Years With Diabetes, Medical Expendit-
ure Panel Survey 2011 and 2012
Measurea
≤138% Federal Poverty Level >138% Federal Poverty Level
Uninsured (95%





Access to and use of health care in 2011 or 2012
Had a usual source of care 69.0 (60.6–77.5) 89.5 (86.3–92.7) <.001 77.1 (71.0–83.1) 94.6
(93.1–96.1)
<.001
Unable to access necessary
medical care
18.5 (12.7–24.4) 6.5 (4.1–8.8) <.001 13.8 (7.9–19.6) 2.5 (1.6–3.5) <.001
Unable to get necessary
prescription medications
17.6 (11.1–24.2) 6.4 (3.9–8.9) .002 9.0 (3.9–14.1) 4.0 (2.7–5.3) .06
HbA1c test 83.4 (76.4–91.3) 95.6 (93.2–98.0) .003 86.6 (79.2–94.0) 97.5
(96.5–98.6)
.004
Feet checked 48.5 (38.9–58.0) 67.0 (62.7–71.3) <.001 49.9 (40.1–59.7) 69.6
(66.6–72.7)
<.001
Eye examination 35.9 (27.5–44.2) 58.1 (52.7–63.3) <.001 38.8 (30.2–47.4) 65.6
(62.1–69.1)
<.001
Cholesterol check 66.2 (58.5–73.9) 77.4 (73.2–81.6) .015 69.5 (62.4–76.6) 88.1
(85.8–90.2)
<.001
Influenza vaccine 32.4 (25.3–39.6) 57.2 (51.4–62.9) <.001 37.8 (28.1–47.5) 61.8
(58.6–64.9)
<.001
Blood pressure check 84.4 (79.3–89.4) 96.5 (94.4–98.6) <.001 90.3( 86.7–94.0) 98.1
(97.4–98.8)
<.001
Office visits, mean no. 4.1 (3.0–5.2) 11.0 (8.8–13.1) <.001 4.6 (3.5–5.6) 8.8 (7.9–9.7) <.001
Office visits, median no. 2 5 <.001 3 5 <.001
Total prescription fills in year,
mean
23.4 (18.7–28.0) 51.3 (43.9–58.7) <.001 23.5 (18.4–28.6) 36.2
(34.0–38.6)
<.001
Total prescription fills in year,
median
17 37 <.001 15 25 <.001
Any emergency department
visit
19.3 (14.7–24.0) 33.3 (28.3–38.2) <.001 22.9 (16.4–29.4) 21.9
(19.3–24.6)
.79
Any inpatient nights 8.9 (5.2–12.6) 25.6 (20.8–30.3) <.001 10.9 (5.7–16.1) 14.7
(12.3–17.1)
.22










Total, median 1,297 6,382 <.001 1,483 4,767 <.001
Out-of-pocket, mean 1,177
(837–1,516)





Out-of-pocket, median 432 225 .005 795 808 .09
Abbreviation: CI, confidence interval.
a Values are percentages unless otherwise stated.
b Tests of significance were computed using survey-specific t tests for continuous variables, proportions tests for binary variables, and nonparametric k-
sample tests for medians. All results were weighted to be nationally representative.
c Expenditures are as reported in current-year dollars. Measures refer to the full calendar year for respondents in either the 2011 or 2012 household
component full-year consolidated Medical Expenditure Panel Survey data files. Samples were pooled as described in the methods section.
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(continued)
Table 2. Health Care Access, Use, and Expenditures of US Adults Aged 19 to 64 Years With Diabetes, Medical Expendit-
ure Panel Survey 2011 and 2012
Measurea
≤138% Federal Poverty Level >138% Federal Poverty Level
Uninsured (95%


















355 1,894 <.001 346 1,744 <.001
Abbreviation: CI, confidence interval.
a Values are percentages unless otherwise stated.
b Tests of significance were computed using survey-specific t tests for continuous variables, proportions tests for binary variables, and nonparametric k-
sample tests for medians. All results were weighted to be nationally representative.
c Expenditures are as reported in current-year dollars. Measures refer to the full calendar year for respondents in either the 2011 or 2012 household
component full-year consolidated Medical Expenditure Panel Survey data files. Samples were pooled as described in the methods section.
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